Categories Industrials

What to expect when Southwest Airlines (LUV) reports Q3 results

Southwest Airlines Co. (NYSE: LUV) is slated to report third quarter 2019 earnings results on Thursday, October 24, before the market opens. Analysts estimate the company will report earnings of $1.08 per share which is flat compared to the prior-year period. Revenue is expected to inch up by 1% to $5.64 billion.

Like its peers, Southwest’s third quarter results will be impacted by the 737 Max groundings. The airline is tackling higher costs and lower capacity due to the groundings. However, strong customer demand and a higher passenger yield will help provide a cushion.

Southwest Airlines reports Q2 2019 earnings results

Last quarter, Southwest saw a 6.8% increase in unit revenues, and the company expects strong unit revenue growth in the third quarter. The company will also benefit from lower fuel costs. Unit revenues are expected to increase 3-5% in the third quarter while unit costs, excluding fuel, are projected to rise 9-11%.

Capacity is expected to drop 2-3% and fuel efficiency is expected to decrease 1-2% year-over-year due to the Max groundings in the third quarter. Economic fuel costs are estimated to be $2.05-2.15 per gallon.

Also read: JetBlue Q3 2019 Earnings Report

In the second quarter of 2019, Southwest beat earnings estimates but missed the mark on revenue. Revenues rose 3% to $5.90 billion but was below the estimated $5.94 billion. Adjusted EPS grew 9% to $1.37. Capacity dropped 3.6% while unit costs increased 7.5%.

For the full year of 2019, Southwest expects unit costs (CASM), excluding fuel, oil and profit-sharing expenses, to increase 8-10% year-over-year. Capacity is estimated to drop 1-2%.

Shares of Southwest have gained 12% year-to-date. The stock was down 1% in afternoon trade on Tuesday.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top